Skip to content

The effect of Low Dose Aspirin towards Gut Microbita

The effect of Low Dose Aspirin towards Gut Microbita - Aspirin and Gut Microbiota

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000032644
Enrollment
20
Registered
2018-06-01
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All conditions which requires beginning of aspirin use

Interventions

None listed

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients newly administrated to take low dose aspirin, and have agreed to enter this study

Exclusion criteria

Exclusion criteria: 1 Use of NSAID, antibiotics, or probiotics within one month before entering the trial 2 Past history of intestinal inflammatory disease 3 Patients with intestinal stenosis 4 Patients with severe disorder of liver, kidney, neuro system, or mental 5 Possibility of pregnancy 6 Other situation which the chief investigator judge as inadequate

Design outcomes

Primary

MeasureTime frame
Evaluation of the fecal microbiota using NGS

Countries

Japan

Contacts

Public ContactKeiichi Ashikari

Yokohama City University Department of Gastroenterology and Hepatology

kei1.ashikari@gmail.com045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026